Completed PHASE2 INTERVENTIONAL 1-arm NCT00053209

Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium

Phase II Trial Of Pemetrexed Disodium And Gemcitabine In Advanced Urothelial Cancer

Sponsor: Eastern Cooperative Oncology Group

Conditions Bladder Cancer Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer

Interventions gemcitabine hydrochloride pemetrexed disodium

Updated 8 times since 2017 Last updated: Jun 20, 2023 Started: Aug 10, 2004 Primary completion: Sep 30, 2007 Completion: May 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Bladder Cancer and Transitional Cell Cancer of the Renal Pelvis and Ureter, this trial is completed. The trial is conducted by Eastern Cooperative Oncology Group and has accumulated 8 data snapshots since 2004. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jul 2023 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2023 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Aug 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Data source: Eastern Cooperative Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aiken, United States , Ames, United States , Athens, United States , Augusta, United States , Aurora, United States , Bemidji, United States , Bethlehem, United States , Boulder, United States , Burnsville, United States , Camden, United States and 80 more locations